Business4 sources
Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round
Bloomberg Technology · By Rebecca Torrence & Shirin Ghaffary ·
The Brief · written from 4 sources
- Isomorphic Labs, Alphabet's AI drug-discovery company, raised a $5 billion Series C led by Sequoia and Greenoaks.
- The round came about six months after a $2.1 billion raise and follows a $600 million raise in March 2025.
- The company has no approved drugs yet and plans to use the funding to move its drug candidates toward clinical trials.
Why it matters
It signals large investor backing for AI-driven drug design and a push to move candidates into clinical trials, which is the stage where AI-discovered drugs will be tested against real outcomes.
Alphabet Inc.’s Isomorphic Labs, which is working to design new drugs with artificial intelligence, has raised $5 billion in a funding round helmed by Silicon Valley titans just six months after announcing its last fundraising effort.
Timeline
Full coverage · 4 sources
- 11h ago ↗
- 11h ago ↗
AI News & Artificial Intelligence | TechCrunch
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials - 14h ago ↗
- 14h ago ↗
Bloomberg Technology
Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round